Mandate

Vinge has advised Sveafastigheter in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Sveafastigheter AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm. The prospectus was published on 13 June 2025 and the trading on Nasdaq Stockholm commenced on 18 June 2025.

Sveafastigheter is a real estate company that owns, actively manages and develops residential properties throughout Sweden with a focus on rental apartments in selected growth regions. The property portfolio consists of standing assets, ongoing construction and project development with a total property value of approximately SEK 28.2 billion.

Vinge’s team has primarily consisted of Rikard Lindahl, Benjamin Vafaeian, Filip Magnusson and  Carl Lexenberg (Capital Markets and Public M&A), Victor Ericsson, Emelie Svanberg, Erik Kochbati and Marcus Svärd (Corporate Tax), Emil Lindwall and Agnes Pigg (Employment), Felix Möller and William Carlberg Johansson (Financing), Ian Jonson (IPR), Kristoffer Larson (Real Estate) and Diana Kanold (VDR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026